Prostaglandin API Supply

About River Stone Biotech

River Stone Biotech is a private, Copenhagen-based company leveraging a hybrid synthetic biology and chemistry platform to reinvent the supply chain for high-value, complex APIs. Its initial commercial focus is on producing opioid use disorder treatments and prostaglandins, aiming to reduce cost, complexity, and environmental impact. The company has secured key patents, published significant research, and announced a global commercial launch as of late 2023, positioning it as a disruptive specialty API manufacturer.

Therapeutic Areas